-
1
المؤلفون: Katarzyna Kolasa, Cezary Sciborski, Phil McEwan, Leszek Czupryniak, Isabelle Duprat Lomon, Władysław Grzeszczak
المصدر: Diabetes Technology & Therapeutics. 14:65-73
مصطلحات موضوعية: Male, medicine.medical_specialty, Cost effectiveness, Cost-Benefit Analysis, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Insulin, Isophane, Adamantane, NPH insulin, Type 2 diabetes, Saxagliptin, chemistry.chemical_compound, Endocrinology, Diabetes mellitus, Internal medicine, medicine, Humans, Hypoglycemic Agents, Glycated Hemoglobin, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Insulin, Type 2 Diabetes Mellitus, Dipeptides, Middle Aged, medicine.disease, Metformin, Medical Laboratory Technology, Models, Economic, Sulfonylurea Compounds, Diabetes Mellitus, Type 2, chemistry, Drug Therapy, Combination, Female, Poland, Quality-Adjusted Life Years, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aabf8fda99080d04d76581547510f69Test
https://doi.org/10.1089/dia.2011.0092Test -
2
المؤلفون: David R. Owens, Geremia B. Bolli
المصدر: Diabetes Technology & Therapeutics. 10:333-349
مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Molecular Sequence Data, Insulin, Isophane, Insulin Glargine, NPH insulin, Type 2 diabetes, Endocrinology, Insulin Detemir, Internal medicine, Diabetes mellitus, Diabetes Mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, Glucose homeostasis, Amino Acid Sequence, Insulin detemir, Insulin glargine, business.industry, medicine.disease, Insulin, Long-Acting, Medical Laboratory Technology, Basal (medicine), business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::905a2f14397936f322f2277fa3c0cb04Test
https://doi.org/10.1089/dia.2008.0023Test -
3
المؤلفون: George Dailey, Poul Strange, Matthew C. Riddle
المصدر: Diabetes Technology & Therapeutics. 11:477-479
مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Insulin, Isophane, Insulin Glargine, NPH insulin, Type 2 diabetes, Hypoglycemia, Endocrinology, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, In patient, Intensive care medicine, Insulin glargine, business.industry, Treat to target, medicine.disease, Insulin, Long-Acting, Medical Laboratory Technology, Sulfonylurea Compounds, Diabetes Mellitus, Type 2, Glucagon Injection, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b2446f8ec0cca8311a25e32d6075b8Test
https://doi.org/10.1089/dia.2009.0022Test -
4
المؤلفون: Stephen N. Davis, Maka S. Hedrington, Lindsay Pulliam
المصدر: Diabetes Technology & Therapeutics. 13:S-33
مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Insulin Glargine, Insulin analog, NPH insulin, Invited Articles, Type 2 diabetes, Hypoglycemia, Endocrinology, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, Insulin detemir, Glycated Hemoglobin, Clinical Trials as Topic, business.industry, Insulin glargine, medicine.disease, Insulin, Long-Acting, Medical Laboratory Technology, Diabetes Mellitus, Type 2, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce38d81070635583c49cc7c6fe522d78Test
https://doi.org/10.1089/dia.2011.0062Test